VAERS reports by lot

GSK Varicella/Shingles lot HY4GT: VAERS reports

54 VAERS reports list lot HY4GT as a GSK Varicella/Shingles vaccine, received between 2019-06-12 and 2022-07-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
54
Reports
2%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5030%
General / Systemic (non-local)4326%
Dermatological (non-injection-site)2817%
Musculoskeletal117%
Neurological95%
Cardiac / Cardiovascular85%
Gastrointestinal53%
Allergic / Anaphylactic42%
Respiratory42%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas9
Pennsylvania6
Arkansas5
Georgia5
Florida4
Kentucky4
New Jersey2
Delaware2
Missouri2
North Carolina2
Tennessee2
South Dakota1

Reports by month received

2019-065
2019-0714
2019-089
2019-096
2019-106
2019-115
2019-121
2020-011
2020-034
2020-071
2021-011
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.